-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Rallybio Corporation (NASDAQ:RLYB) rose sharply in today's pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
Rallybio shares jumped rose 77.9% to $2.90 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Rent the Runway, Inc. (NASDAQ:RENT) shares rose 40.8% to $10.42 in pre-market trading after the company reported mixed fourth-quarter financial results and issued guidance.
- Alpine Immune Sciences, Inc. (NASDAQ:ALPN) gained 36.1% to $64.02 in pre-market trading after Vertex entered into an agreement to acquire the company.
- TuanChe Limited (NASDAQ:TC) shares gained 24.4% to $2.24 in pre-market trading after falling 8% on Wednesday.
- Verb Technology Company, Inc. (NASDAQ:VERB) gained 18.5% to $0.2156 in pre-market trading after gaining 4% on Wednesday.
- Vera Therapeutics, Inc. (NASDAQ:VERA) climbed 13.1% to $47.06 in pre-market trading after gaining 10% on Wednesday.
- BitFuFu Inc. (NASDAQ:FUFU) shares gained 12.5% to $4.90 in pre-market trading after reporting full year 2023 financial results.
- Allarity Therapeutics, Inc. (NASDAQ:ALLR) rose 10.2% to $3.56 in pre-market trading after dipping 10% on Wednesday.
- CuriosityStream Inc. (NASDAQ:CURI) gained 10.8% to $1.58 in pre-market trading after surging over 10% on Wednesday. Curiosity Stream, on March 20, reported mixed fourth-quarter financial results.
- SciSparc Ltd. (NASDAQ:SPRC) shares rose 8.3% to $1.82 in pre-market trading.
Losers
- Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 31.3% to $1.65 in pre-market trading. Aptevo Therapeutics recently issued pipeline update.
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 17.7% to $0.7158 in pre-market trading after declining 14% on Wednesday. Acorda Therapeutics recently commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
- ClearOne, Inc. (NASDAQ:CLRO) declined 17.1% to $0.9046 in pre-market trading. The company recently reported fourth-quarter financial results.
- SolarBank Corporation (NASDAQ:SUUN) fell 14.4% to $4.98 in pre-market trading. SolarBank closed purchase of 3.15 MW solar project in New York from Storke Renewable.
- Meiwu Technology Company Limited (NASDAQ:WNW) shares declined 13.4% to $1.15 in pre-market trading after jumping around 32% on Wednesday.
- Novo Integrated Sciences, Inc. (NASDAQ:NVOS) fell 12.7% to $0.4452 pre-market trading after declining around 4% on Wednesday.
- iCoreConnect Inc. (NASDAQ:ICCT) shares fell 9.5% to $1.53 in pre-market trading after jumping over 50% on Wednesday.
- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares fell 9.3% to $2.11 in pre-market trading. Adial Pharmaceuticals shares jumped 106% on Wednesday after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered AD04.
- Nyxoah S.A. (NASDAQ:NYXH) fell 8.3% to $9.74 in pre-market trading.
- AVITA Medical, Inc. (NASDAQ:RCEL) fell 4.2% to $13.83 pre-market trading after the company announced an update to its expected commercial revenue for the first quarter of 2024.
Now Read This: Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20
Shares of Rallybio Corporation (NASDAQ:RLYB) rose sharply in today's pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
Rallybio Corporation(纳斯达克股票代码:RLYB)的股价在今天的盘前交易中大幅上涨,此前该公司宣布与强生公司合作,推进针对面临FNAIT风险的孕妇的治疗方案。
Rallybio shares jumped rose 77.9% to $2.90 in pre-market trading.
在盘前交易中,Rallybio股价上涨77.9%,至2.90美元。
Here are some other stocks moving in pre-market trading.
以下是盘前交易中其他一些股票。
Gainers
获胜者
- Rent the Runway, Inc. (NASDAQ:RENT) shares rose 40.8% to $10.42 in pre-market trading after the company reported mixed fourth-quarter financial results and issued guidance.
- Alpine Immune Sciences, Inc. (NASDAQ:ALPN) gained 36.1% to $64.02 in pre-market trading after Vertex entered into an agreement to acquire the company.
- TuanChe Limited (NASDAQ:TC) shares gained 24.4% to $2.24 in pre-market trading after falling 8% on Wednesday.
- Verb Technology Company, Inc. (NASDAQ:VERB) gained 18.5% to $0.2156 in pre-market trading after gaining 4% on Wednesday.
- Vera Therapeutics, Inc. (NASDAQ:VERA) climbed 13.1% to $47.06 in pre-market trading after gaining 10% on Wednesday.
- BitFuFu Inc. (NASDAQ:FUFU) shares gained 12.5% to $4.90 in pre-market trading after reporting full year 2023 financial results.
- Allarity Therapeutics, Inc. (NASDAQ:ALLR) rose 10.2% to $3.56 in pre-market trading after dipping 10% on Wednesday.
- CuriosityStream Inc. (NASDAQ:CURI) gained 10.8% to $1.58 in pre-market trading after surging over 10% on Wednesday. Curiosity Stream, on March 20, reported mixed fourth-quarter financial results.
- SciSparc Ltd. (NASDAQ:SPRC) shares rose 8.3% to $1.82 in pre-market trading.
- Rent the Runway, Inc.(纳斯达克股票代码:RENT)股价在盘前交易中上涨40.8%,至10.42美元,此前该公司公布了喜忧参半的第四季度财务业绩并发布了指引。
- 在Vertex签订收购阿尔卑斯免疫科学公司(纳斯达克股票代码:ALPN)的盘前交易中上涨36.1%,至64.02美元。
- 团车有限公司(纳斯达克股票代码:TC)股价在周三下跌8%后,在盘前交易中上涨24.4%,至2.24美元。
- Verb Technology Company, Inc.(纳斯达克股票代码:VERB)在周三上涨4%后,在盘前交易中上涨18.5%,至0.2156美元。
- Vera Therapeutics, Inc.(纳斯达克股票代码:VERA)在周三上涨10%后,在盘前交易中上涨13.1%,至47.06美元。
- BitFuFu公司(纳斯达克股票代码:FUFU)在公布2023年全年财务业绩后,股价在盘前交易中上涨12.5%,至4.90美元。
- Allarity Therapeutics, Inc.(纳斯达克股票代码:ALLR)在周三下跌10%后,在盘前交易中上涨10.2%,至3.56美元。
- CuriosityStream Inc.(纳斯达克股票代码:CURI)在周三飙升超过10%后,在盘前交易中上涨10.8%,至1.58美元。3月20日,Curiosity Stream公布了喜忧参半的第四季度财务业绩。
- ScisPARC Ltd.(纳斯达克股票代码:SPRC)股价在盘前交易中上涨8.3%,至1.82美元。
Losers
失败者
- Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 31.3% to $1.65 in pre-market trading. Aptevo Therapeutics recently issued pipeline update.
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 17.7% to $0.7158 in pre-market trading after declining 14% on Wednesday. Acorda Therapeutics recently commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
- ClearOne, Inc. (NASDAQ:CLRO) declined 17.1% to $0.9046 in pre-market trading. The company recently reported fourth-quarter financial results.
- SolarBank Corporation (NASDAQ:SUUN) fell 14.4% to $4.98 in pre-market trading. SolarBank closed purchase of 3.15 MW solar project in New York from Storke Renewable.
- Meiwu Technology Company Limited (NASDAQ:WNW) shares declined 13.4% to $1.15 in pre-market trading after jumping around 32% on Wednesday.
- Novo Integrated Sciences, Inc. (NASDAQ:NVOS) fell 12.7% to $0.4452 pre-market trading after declining around 4% on Wednesday.
- iCoreConnect Inc. (NASDAQ:ICCT) shares fell 9.5% to $1.53 in pre-market trading after jumping over 50% on Wednesday.
- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares fell 9.3% to $2.11 in pre-market trading. Adial Pharmaceuticals shares jumped 106% on Wednesday after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered AD04.
- Nyxoah S.A. (NASDAQ:NYXH) fell 8.3% to $9.74 in pre-market trading.
- AVITA Medical, Inc. (NASDAQ:RCEL) fell 4.2% to $13.83 pre-market trading after the company announced an update to its expected commercial revenue for the first quarter of 2024.
- Aptevo Therapeutics Inc.(纳斯达克股票代码:APVO)在盘前交易中下跌31.3%,至1.65美元。Aptevo Therapeutics最近发布了管道更新。
- Acorda Therapeutics, Inc.(纳斯达克股票代码:ACOR)在周三下跌14%后,在盘前交易中下跌17.7%,至0.7158美元。Acorda Therapeutics最近根据美国《破产法》第11章启动了自愿程序。
- ClearOne, Inc.(纳斯达克股票代码:CLRO)在盘前交易中下跌17.1%,至0.9046美元。该公司最近公布了第四季度财务业绩。
- SolarBank Corporation(纳斯达克股票代码:SUUN)在盘前交易中下跌14.4%,至4.98美元。SolarBank完成了对Storke Renewable在纽约的3.15兆瓦太阳能项目的收购。
- 美武科技有限公司(纳斯达克股票代码:WNW)股价在周三上涨约32%后,在盘前交易中下跌13.4%,至1.15美元。
- Novo Integrated Sciences, Inc.(纳斯达克股票代码:NVOS)在周三下跌约4%后,盘前交易中下跌12.7%,至0.4452美元。
- iCoreConnect Inc.(纳斯达克股票代码:ICCT)股价在周三上涨了50%后,在盘前交易中下跌9.5%,至1.53美元。
- 阿迪尔制药公司(纳斯达克股票代码:ADIL)股价在盘前交易中下跌9.3%,至2.11美元。Adial Pharmicals的股价周三上涨了106%,此前该公司宣布发表了一篇经过同行评审的文章,该文章重点介绍了AD04患者的临床结果、良好的安全性以及较高的依从性。
- Nyxoah S.A.(纳斯达克股票代码:NYXH)在盘前交易中下跌8.3%,至9.74美元。
- AVITA Medical, Inc.(纳斯达克股票代码:RCEL)在盘前交易中下跌4.2%,至13.83美元,此前该公司宣布更新其2024年第一季度的预期商业收入。
Now Read This: Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20
现在读这个: 吉姆·克莱默说WESCO International值得买入,建议在20美元以下买入这只股票
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧